Laura Cavalleri
Bergamo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Treatment Adaptation to Surgical Timing in Pediatric Hepatoblastoma: A 19-Year Single-Center Experience With Resection and Liver Transplantation.
Journal: Pediatric transplantation
Published: June 17, 2026
Single transient exposure to low-frequency low-intensity electrical stimulation produces ketamine-like effects in human iPSC-derived dopaminergic neurons via Ca2+-dependent BDNF and mTOR signaling.
Journal: Neuropharmacology
Published: February 17, 2026
Cortisol-dependent impairment of dendrite plasticity in human dopaminergic neurons derived from hiPSCs is restored by ketamine: Relevance for major depressive disorders.
Journal: Neuroscience applied
Published: October 25, 2023
Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression.
Journal: Current topics in behavioral neurosciences
Published: May 10, 2022
Vitamin B12 deficiency presenting as intestinal pseudo-obstruction in short bowel syndrome: A case report.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: May 05, 2022
Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons.
Journal: Frontiers in pharmacology
Published: April 05, 2022
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist.
Journal: European journal of pharmacology
Published: May 02, 2020
Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant Depression.
Journal: Chronic stress (Thousand Oaks, Calif.)
Published: March 02, 2019
Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors.
Journal: Neuroreport
Published: March 24, 2018
Last Updated: 09/26/2026